Bacterial Meningitis in Adults: Analysis of the Determinants of Mortality and Neurosensory Sequelae (COMBAT)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01730690|
Recruitment Status : Completed
First Posted : November 21, 2012
Last Update Posted : July 5, 2017
Major changes in the epidemiological characteristics of bacterial meningitis have been observed as a result of changes in behaviour, human interventions (use of antibiotics, prophylactic vaccinations), as well as poorly elucidated mechanisms responsible for epidemic outbreaks.
The objective of this study is to identify the determinants of in-hospital mortality of bacterial meningitis in adults.
Hypothesis : the standardized data collection concerning cases of bacterial meningitis in adults with telephone follow-up would allow analysis of the determinants of mortality and neurosensory sequelae, description of the psychosocial impact and proposal of new treatment strategies.
|Condition or disease|
Show Detailed Description
|Study Type :||Observational|
|Actual Enrollment :||527 participants|
|Official Title:||Bacterial Meningitis in Adults: Analysis of the Determinants of Mortality and Neurosensory Sequelae|
|Study Start Date :||March 2013|
|Actual Primary Completion Date :||June 2017|
|Actual Study Completion Date :||June 2017|
- In-hospital mortality [ Time Frame: 30 days ]mortality in hospital at 30 days
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01730690
|Assistance Publique des Hôpitaux de Paris|
|Principal Investigator:||Xavier duval||APHP|